The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

SABCS 2019 Updates on Metastatic HR+ BC: PEARL Suggests Treatment With Palbociclib + ET Is Generally Better Tolerated Than Capecitabine

240 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login